Department of Anesthesiology
[ Author(Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
Memtsoudis SG, Kerr GE.  2004.  Glycopyrrolate as an alternative to vasopressor infusion for hypotension after carotid endarterectomy.. Anaesth Intensive Care. 32(3):434-5.
Memtsoudis SG, The AHS, Heerdt PM.  2005.  Autonomic mechanisms in the age-related hypotensive effect of propofol.. Anesth Analg. 100(1):111-5.
Memtsoudis SG, Stundner O, Sun X, Chiu Y-L, Ma Y, Fleischut P, Kerr GE, Girardi FP, J Walz M.  2013.  Critical Care in Patients Undergoing Lumbar Spine Fusion: A Population-Based Study.. J Intensive Care Med.
Memtsoudis SG, Stundner O, Rasul R, Sun X, Chiu Y-L, Fleischut P, Danninger T, Mazumdar M.  2013.  Sleep apnea and total joint arthroplasty under various types of anesthesia: a population-based study of perioperative outcomes.. Reg Anesth Pain Med. 38(4):274-81.
Memtsoudis SG, Ivascu NS, Pryor KO, Goldstein PA.  2020.  Obesity as a risk factor for poor outcome in COVID-19-induced lung injury: the potential role of undiagnosed obstructive sleep apnoea.. Br J Anaesth.
Meltzer EC, Ivascu NS, Acres CA, Stark M, Furman RR, Fins JJ.  2014.  Extracorporeal membrane oxygenation as a bridge to chemotherapy in an Orthodox Jewish patient.. Oncologist. 19(9):985-9.
Meltzer EC, Ivascu NS, Stark M, Orfanos AV, Acres CA, Christos PJ, Mangione T, Fins JJ.  2016.  A Survey of Physicians' Attitudes toward Decision-Making Authority for Initiating and Withdrawing VA-ECMO: Results and Ethical Implications for Shared Decision Making.. J Clin Ethics. 27(4):281-289.
Meltzer ECowen, Ivascu NS, Fins JJ.  2014.  DNR and ECMO: a paradox worth exploring.. J Clin Ethics. 25(1):13-9.
Meltzer EC, Ivascu NS, Edwin MK, Ingall TJ.  2019.  Should Long-Term Life-Sustaining Care Be Started in Emergency Settings? AMA J Ethics. 21(5):E401-406.
Meltzer EC, Ivascu NS, Acres CA, Stark M, Kirkpatrick JN, Paul S, Sedrakyan A, Fins JJ.  2014.  Extracorporeal membrane oxygenation in adults: a brief review and ethical considerations for nonspecialist health providers and hospitalists.. J Hosp Med. 9(12):808-13.
Meister B, Fried G, Hökfelt T, Hemmings HC, Greengard P.  1988.  Immunohistochemical evidence for the existence of a dopamine- and cyclic AMP-regulated phosphoprotein (DARPP-32) in brown adipose tissue of pigs.. Proc Natl Acad Sci U S A. 85(22):8713-6.
Meister B, Askergren J, Tunevall G, Hemmings HC, Greengard P.  1991.  Identification of a dopamine- and 3'5'-cyclic adenosine monophosphate-regulated phosphoprotein of 32 kD (DARPP-32) in parathyroid hormone-producing cells of the human parathyroid gland.. J Endocrinol Invest. 14(8):655-61.
Meister B, Arvidsson U, Hemmings HC, Greengard P, Hökfelt T.  1991.  Dopamine- and adenosine-3':5'-monophosphate (cAMP)-regulated phosphoprotein of Mr 32,000 (DARPP-32) in the retina of cat, monkey and human.. Neurosci Lett. 131(1):66-70.
Meister B, Schultzberg M, Hemmings HC, Greengard P, Goldstein M, Hökfelt T.  1991.  Dopamine- and adenosine-3',5'-monophosphate (cAMP)-regulated phosphoprotein of 32 kDa (DARPP-32) in the adrenal gland: immunohistochemical localization.. J Auton Nerv Syst. 36(1):75-84.
Meister B, Fryckstedt J, Schalling M, Cortés R, Hökfelt T, Aperia A, Hemmings HC, Nairn AC, Ehrlich M, Greengard P.  1989.  Dopamine- and cAMP-regulated phosphoprotein (DARPP-32) and dopamine DA1 agonist-sensitive Na+,K+-ATPase in renal tubule cells.. Proc Natl Acad Sci U S A. 86(20):8068-72.
Mehta N, Inturrisi CE, Horn SD, Witkin LR.  2016.  Using Chronic Pain Outcomes Data to Improve Outcomes.. Anesthesiol Clin. 34(2):395-408.
Mehta N, O'Connell K, Giambrone GP, Baqai A, Diwan S.  2016.  Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review.. Postgrad Med. :1-8.
Mehta N, Slatkin NE, Israel RJ, Stambler N.  2021.  Attrition of methylnaltrexone treatment-emergent adverse events in patients with chronic noncancer pain and opioid-induced constipation: a post hoc pooled analysis of two clinical trials.. F1000Res. 10:891.
Mehta N, Zocca J, Shaparin N, Snyder M, Singh JR.  2016.  Intravenous Conscious Sedation for Routine Fluoroscopically Guided Lumbar Interventions.. PM R. 8(4):373-9.
Mehta N, Slatkin NE, Israel RJ, Stambler N, Shah ED.  2023.  Impact of Patient Subgroups on the Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients with Advanced Illness.. J Pain Res. 16:3529-3543.
Mehta N, Bucior I, Bujanover S, Shah, iv R, Gulati A.  2016.  Relationship between pain relief, reduction in pain-associated sleep interference, and overall impression of improvement in patients with postherpetic neuralgia treated with extended-release gabapentin.. Health Qual Life Outcomes. 14:54.
Meed SD, Kleinman PM, Kantor TG, Blum RH, Savarese JJ.  1987.  Management of cancer pain with oral controlled-release morphine sulfate.. J Clin Pharmacol. 27(2):155-61.
Meco BCeyda, Jakobsen K, De Robertis E, Buhre W, Alkış N, Kirkegaard PRoy, Hägi-Pedersen D, Bubser F, Koch S, Evered LA et al..  2024.  A first assessment of the safe brain initiative care bundle for addressing postoperative delirium in the postanesthesia care unit.. J Clin Anesth. 97:111506.
Mears J, Kaleem S, Panchamia R, Kamel H, Tam C, Thalappillil R, Murthy S, Merkler AE, Zhang C, Ch'ang JH.  2024.  Leveraging the Capabilities of AI: Novice Neurology-Trained Operators Performing Cardiac POCUS in Patients with Acute Brain Injury.. Neurocrit Care.
McKenna JT, Cordeira JW, Christie MA, Tartar JL, McCoy JG, Lee E, McCarley RW, Strecker RE.  2008.  Assessing sleepiness in the rat: a multiple sleep latencies test compared to polysomnographic measures of sleepiness.. J Sleep Res. 17(4):365-75.